This Article Full Text Full Text (PDF) All Versions of this Article: 47/2/203    most recent 01.HYP.0000200042.64517.19v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Salas, S. P. Articles by Rosso, P. Search for Related Content PubMed PubMed Citation Articles by Salas, S. P. Articles by Rosso, P. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ESTRADIOL PROGESTERONE Medline Plus Health Information High Risk Pregnancy Hormones Pregnancy Related Collections Clinical Studies Other hypertension

(Hypertension. 2006;47:203.)
© 2006 American Heart Association, Inc.

Original Articles

Time Course of Maternal Plasma Volume and Hormonal Changes in Women With Preeclampsia or Fetal Growth Restriction

From the Departments of Obstetrics and Gynecology (S.P.S.), Public Health (G.M.), and Pediatrics (P.R.) and Center for Medical Research (S.P.S., B.L.G., P.R.), School of Medicine Pontificia Universidad Católica de Chile, Sandiago, Chile.

Correspondence to Sofía P. Salas, Center for Medical Research, School of Medicine, Pontificia Universidad Católica de Chile, Marcoleta 391, Santiago, Chile. E-mail ssalas{at}med.puc.cl

We tested the hypothesis that women with idiopathic fetal growth restriction (FGR) or preeclampsia (PE) have lower concentrations of some water-retaining hormones, such as aldosterone and estradiol, either preceding or concomitant with the onset of the reduced plasma volume described in these women. Plasma volume and serum concentrations of estradiol, progesterone, and aldosterone were measured serially at monthly intervals in 135 pregnant women from week 10 until term. Twenty-three developed idiopathic FGR, 17 had PE, and 95 remained normotensive and delivered normal-size infants (controls). Changes over time for each variable were studied using mixed models. Maternal age, parity, and weight/height at term were similar in all of the groups. Birth weight, body length, and ponderal index were lower in FGR and PE than in controls. Plasma volume increased throughout pregnancy in controls but was lower in FGR and PE from week 14 to 17 until term. Aldosterone values were lower in PE from week 26 to 29 onwards and in FGR after week 34. Progesterone concentrations were higher in PE than either control or FGR from week 18 to 21 until term. In contrast, FGR pregnancies had reduced progesterone and estradiol concentrations after week 34. Progesterone:estradiol ratio was significantly higher only in the PE group. In mothers with idiopathic FGR or PE, less expansion in plasma volume occurred before alterations in hormonal concentrations. We speculate that the early rise in progesterone may have a pathogenic role in the development of preeclampsia.

Key Words: blood • aldosterone • preeclampsia • estrogen

This article has been cited by other articles:

				B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF]

				M. Vore and M. Leggas Progesterone Acts via Progesterone Receptors A and B to Regulate Breast Cancer Resistance Protein Expression Mol. Pharmacol., March 1, 2008; 73(3): 613 - 615. [Abstract] [Full Text] [PDF]

				G.-F. von Tempelhoff, L. Heilmann, L. Rudig, K. Pollow, G. Hommel, and J. Koscielny Mean Maternal Second-Trimester Hemoglobin Concentration and Outcome of Pregnancy: A Population-Based Study Clinical and Applied Thrombosis/Hemostasis, January 1, 2008; 14(1): 19 - 28. [Abstract] [PDF]

				S. Sena, I. R. Rasmussen, A. R. Wende, A. P. McQueen, H. A. Theobald, N. Wilde, R. O. Pereira, S. E. Litwin, J. P. Berger, and E. D. Abel Cardiac Hypertrophy Caused by Peroxisome Proliferator- Activated Receptor-{gamma} Agonist Treatment Occurs Independently of Changes in Myocardial Insulin Signaling Endocrinology, December 1, 2007; 148(12): 6047 - 6053. [Abstract] [Full Text] [PDF]

				S. P. Salas, A. Giacaman, W. Romero, P. Downey, E. Aranda, D. Mezzano, and C. P. Vio Pregnant Rats Treated With a Serotonin Precursor Have Reduced Fetal Weight and Lower Plasma Volume and Kallikrein Levels Hypertension, October 1, 2007; 50(4): 773 - 779. [Abstract] [Full Text] [PDF]

				J. M. Faupel-Badger, C.-C. Hsieh, R. Troisi, P. Lagiou, and N. Potischman Plasma Volume Expansion in Pregnancy: Implications for Biomarkers in Population Studies Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1720 - 1723. [Abstract] [Full Text] [PDF]

				L. A. Mucci, P. W. Dickman, M. Lambe, H.-O. Adami, D. Trichopoulos, T. Riman, C.-c. Hsieh, and S. Cnattingius Gestational Age and Fetal Growth in Relation to Maternal Ovarian Cancer Risk in a Swedish Cohort Cancer Epidemiol. Biomarkers Prev., September 1, 2007; 16(9): 1828 - 1832. [Abstract] [Full Text] [PDF]

				J. Joyner, L. A. A. Neves, J. P. Granger, B. T. Alexander, D. C. Merrill, M. C. Chappell, C. M. Ferrario, W. P. Davis, and K. B. Brosnihan Temporal-spatial expression of ANG-(1-7) and angiotensin-converting enzyme 2 in the kidney of normal and hypertensive pregnant rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R169 - R177. [Abstract] [Full Text] [PDF]

				C. Wadsack, S. Tabano, A. Maier, U. Hiden, G. Alvino, V. Cozzi, M. Huttinger, W. J. Schneider, U. Lang, I. Cetin, et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E476 - E484. [Abstract] [Full Text] [PDF]